3 Stocks I'm Not Selling, No Matter What the Market Does for the Next 20 Years

The common thread is not “dividend quality” so much as balance-sheet optionality: each company has enough recurring cash flow to keep paying while also funding a strategic pivot. That matters because in this market, the dividend is increasingly a call option on management discipline; if capex or restructuring slips, the yield will stop being a support and become a warning signal. The second-order winner is not the stock itself but the funding base that lets these firms outlast more cyclical competitors with higher nominal growth but weaker cash conversion.

ENB is the cleanest expression of this because infrastructure cash flows can reprice faster than many investors assume when contract mix, utility exposure, and clean-energy capex are layered in. The underappreciated risk is that “defensive” midstream assets can still become stranded at the margin if capital markets start penalizing anything tied to legacy hydrocarbons, which would push the dividend story from yield premium to value trap over a multi-year horizon. Relative to peers, the market is likely underestimating how much of ENB’s upside depends on maintaining access to low-cost refinancing rather than headline commodity volumes.

PG’s edge is less about recession resistance than about shelf power: premium brands with innovation budgets can force retailers into lower-velocity but higher-margin assortments, which protects gross margin even when unit growth slows. The flip side is that when private label share gains or consumer trade-down become persistent, the market can punish “quality staples” on multiple compression before earnings actually roll over. IBM’s setup is more binary: if the AI and hybrid-cloud mix keeps improving, the stock can re-rate on narrative and cash flow simultaneously; if not, it remains a value trap masked by capital returns. The market appears to be pricing the adaptation story as if it is already proven, when in reality the next 2-4 quarters are the key evidence window.

The contrarian read is that the article’s confidence in long-duration ownership is directionally right but too symmetric: these are not equal-quality defensives. IBM likely has the highest execution beta, ENB the highest policy/refinancing beta, and PG the most stable but also the most crowded ownership base; that means the best risk-adjusted opportunity may be relative value rather than outright longs. In a risk-off tape, capital will rotate into these names, but the biggest upside comes from the market realizing that not all dividend durability deserves the same multiple.